Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy

BACKGROUND: Proprotein convertase subtilisin/kexin 9 (PCSK9) has been proposed as a novel target for coronary artery disease (CAD). Familial hypercholesterolemia (FH) is characterized by high prevalence of CAD and major cardiovascular events (MACEs). However, no data is available on the association...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Ye-Xuan, Jin, Jing-Lu, Sun, Di, Liu, Hui-Hui, Guo, Yuan-Lin, Wu, Na-Qiong, Xu, Rui-Xia, Zhu, Cheng-Gang, Dong, Qian, Sun, Jing, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849213/
https://www.ncbi.nlm.nih.gov/pubmed/31711505
http://dx.doi.org/10.1186/s12967-019-2123-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849213/
https://www.ncbi.nlm.nih.gov/pubmed/31711505
http://dx.doi.org/10.1186/s12967-019-2123-9

Ejemplares similares